髓鞘
中枢神经系统
体内
神经系统
化学
外周神经系统
神经科学
病理
多发性硬化
生物物理学
细胞生物学
生物
医学
免疫学
生物技术
作者
Chunying Wu,Donghua Tian,Yue Feng,Paul E. Polak,Jingjun Wei,Adam Sharp,Bruno Stankoff,Catherine Lubetzki,Bernard Zalc,Elliott Jay Mufson,Robert M. Gould,Douglas L. Feinstein,Yanming Wang
标识
DOI:10.1369/jhc.5a6901.2006
摘要
Myelin is a multilayered glial cell membrane that forms segmented sheaths around large-caliber axons of both the central nervous system (CNS) and peripheral nervous system (PNS). Myelin covering insures rapid and efficient transmission of nerve impulses. Direct visual assessment of local changes of myelin content in vivo could greatly facilitate diagnosis and therapeutic treatments of myelin-related diseases. Current histologic probes for the visualization of myelin are based on antibodies or charged histochemical reagents that do not enter the brain. We have developed a series of chemical compounds including (E,E)-1,4-bis(4'-aminostyryl)-2-dimethoxy-benzene termed BDB and the subject of this report, which readily penetrates the blood-brain barrier and selectively binds to the myelin sheath in brain. BDB selectively stains intact myelinated regions in wild-type mouse brain, which allows for delineation of cuprizone-induced demyelinating lesions in mouse brain. BDB can be injected IV into the brain and selectively detect demyelinating lesions in cuprizone-treated mice in situ. These studies justified further investigation of BDB as a potential myelin-imaging probe to monitor myelin pathology in vivo.
科研通智能强力驱动
Strongly Powered by AbleSci AI